Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: A structured meta-analysis

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 534-542

  Meijer, Johannes A A ^a   Le Cessie, Saskia ^a   Van Den Hout, Wilbert B ^a   Kievit, Job ^a   Schoones, Johannes W ^a   Romijn, Johannes A ^a   Smit, Johannes W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ARTICLE; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HUMAN; META ANALYSIS; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 77749301511     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03666.x     Document Type: Article

References (27)

1. Dralle, H., Damm, I., Scheumann, G.F. et al. (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surgery Today, 24, 112 121.
2. Ukkat, J., Gimm, O., Brauckhoff, M. et al. (2004) Single center experience in primary surgery for medullary thyroid carcinoma. World Journal of Surgery, 28, 1271 1274.
3. Hamy, A., Pessaux, P., Mirallie, E. et al. (2005) Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. European Journal of Surgical Oncology, 31, 774 777.
4. Dotzenrath, C., Goretzki, P.E., Cupisti, K. et al. (2001) Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units. Langenbeck's Archives of Surgery, 386, 47 52.
5. Kebebew, E., Greenspan, F.S., Clark, O.H. et al. (2005) Extent of disease and practice patterns for medullary thyroid cancer. Journal of the American College of Surgeons, 200, 890 896.
6. de Groot, J.W., Links, T.P., Sluiter, W.J. et al. (2007) Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery. Head and Neck, 29, 857 863.
7. Moley, J.F. Fialkowski, E.A. (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World Journal of Surgery, 31, 946 956.
8. Pellegriti, G., Leboulleux, S., Baudin, E. et al. (2003) Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. British Journal of Cancer, 88, 1537 1542.
9. de Groot, J.W.B., Plukker, J.T.M., Wolffenbuttel, B.H.R. et al. (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clinical Endocrinology, 65, 729 736.
10. Weber, T., Schilling, T., Frank-Raue, K. et al. (2001) Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery, 130, 1044 1049.
11. Cupisti, K. (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years. Annals of Surgery, 246, 815 821.
12. Busnardo, B., Girelli, M.E. Simioni, N. (1984) Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer, 53, 278 285.
13. Wells, S.A. Jr., Haagensen, D.E. Jr., Linehan, W.M. et al. (1978) The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42, 3 (Suppl. 1498 1503.
14. Rougier, P., Calmettes, C., Laplanche, A. et al. (1983) The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma. Cancer, 51, 855 862.
15. Hoegerle, S., Altehoefer, C., Ghanem, N. et al. (2001) 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. European Journal of Nuclear Medicine, 28, 64 71.
16. Stepanas, A.V., Samaan, N.A., Hill, C.S. Jr. et al. (1979) Medullary thyroid carcinoma: importance of serial serum calcitonin measurement. Cancer, 43, 825 837.
17. Barbet, J., Campion, L., Kraeber-Bodere, F. et al. (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 90, 6077 6084.
18. Saad, M.F., Fritsche, H.A. Jr. Samaan, N.A. (1984) Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. Journal of Clinical Endocrinology and Metabolism, 58, 889 894.
19. Laure, G.A., Al, G.A., Auperin, A. et al. (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. European Journal of Endocrinology, 158, 239 246.
20. Chatal, J.F., Campion, L., Kraeber-Bodere, F. et al. (2006) Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumour Group. Journal of Clinical Oncology, 24, 1705 1711.
21. Miyauchi, A., Onishi, T., Morimoto, S. et al. (1984) Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Annals of Surgery, 199, 461 466.
22. Miyauchi, A., Matsuzuka, F., Kuma, K. et al. (1988) Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels. World Journal of Surgery, 12, 610 615.
23. Wang, T.S., Ocal, I.T., Sosa, J.A. et al. (2008) Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid, 18, 889 894.
24. Dora, J.M., Canalli, M.H., Capp, C. et al. (2008) Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid, 18, 895 899.
25. Osaka, M., Soga, J., Tamiya, Y. et al. (1999) Dedifferentiation of neoplastic cells in medullary thyroid carcinoma: report of a case. Surgery Today - The Japanese Journal of Surgery, 29, 1189 1194.
26. Leboeuf, R., Langlois, M.F., Martin, M. et al. (2006) "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. Journal of Clinical Endocrinology and Metabolism, 91, 361 364.
27. Palmer, B.V., Harmer, C.L. Shaw, H.J. (1984) Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid. British Journal of Surgery, 71, 101 104.